Infusional Chemotherapy for Non-Hodgkin's Lymphoma
- 1 January 1997
- journal article
- review article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 15 (5) , 465-474
- https://doi.org/10.3109/07357909709047586
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Cell cycle control and cancer chemotherapyJournal of Cellular Biochemistry, 1994
- Infusional Cyclophosphamide, Doxorubicin and Etoposide in HIV-Related Non-Hodgkin's Lymphoma: a Follow-Up Report of a Highly Active RegimenLeukemia & Lymphoma, 1994
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26Biochemical and Biophysical Research Communications, 1984
- Factors Affecting the Pulmonary Toxicity of BleomycinActa Radiologica: Oncology, 1983
- Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancerCancer, 1982
- Threshold Methotrexate Concentration for In Vivo Inhibition of DNA Synthesis in Normal and Tumorous Target TissuesJournal of Clinical Investigation, 1973